Manmeet Soni - 07 Mar 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
COO, CFO and President
Signature
/s/ Tracy Herson, attorney-in-fact
Issuer symbol
RETA
Transactions as of
07 Mar 2023
Net transactions value
-$52,680
Form type
4
Filing time
08 Mar 2023, 16:01:34 UTC
Previous filing
06 Mar 2023
Next filing
09 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Sale $52,680 -622 -0.7% $84.70 88,304 07 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.